US healthcare markets

178 reports across 5 categories, with market size and growth to 2033.

Health in US: WHO figures

US: People and health spending

Companies most covered in US

All 178 US markets

Each market name opens its US report. To compare one market across every country, see market statistics.

Digital Health 41 markets
Digital Health markets in US
Market20232033 (projected)CAGR Active trials
3D Laparoscopy Imaging Systems $1.3 Bn $2.1 Bn 4.7% –
3D Printed Implants $1.5 Bn $4.5 Bn 11.5% –
3D Printing in Medical Application $1 Bn $5.4 Bn 18.3% –
Artificial Intelligence (AI) in Drugs Discovery $252 Mn $2.2 Bn 24.1% 114
Artificial Intelligence (AI) in Healthcare – – – 642
Artificial Intelligence (AI) in Life Sciences $924 Mn $8.4 Bn 24.7% 332
Artificial Intelligence (AI) in Medical Imaging $378 Mn $3 Bn 23.2% 80
Artificial Intelligence (AI) in Medicine $3.5 Bn $72.7 Bn 35.5% 642
Artificial Intelligence (AI) in Pharma – – – –
Artificial Intelligence (AI) in Radiology $252 Mn $2.7 Bn 26.6% –
Artificial Intelligence (AI) in Remote Patient Monitoring $378 Mn $4.6 Bn 28.4% –
Artificial Intelligence (AI) Machine Learning(ML) in Healthcare $798 Mn $17.3 Bn 36% –
Blockchain in Genomics $937 Mn $20.7 Bn 36.3% –
Blockchain-as-a-Service $882 Mn $9.8 Bn 27.3% –
Brain Imaging, Biomarkers and NeuroInformatics $286 Mn $373 Mn 2.7% –
Brain PET-MRI Systems $143 Mn $222 Mn 4.5% –
Clinical Alarm Management $731 Mn $832 Mn 1.3% –
Clinical Data Management Systems $1.1 Bn $2.7 Bn 9.9% –
Connected Healthcare Market $24.7 Bn $231.8 Bn 25.1% –
Decentralized Clinical Trials(DCTs) $689 Mn $2.3 Bn 12.8% –
Dental 3D Printing $1.4 Bn $7.8 Bn 18.5% –
Dental CAD/CAM $1.4 Bn $3 Bn 8% –
Digital Biomarkers $1.8 Bn $33.2 Bn 33.5% –
Digital diabetes care $5.4 Bn $26.6 Bn 17.3% –
Digital Pathology Systems $504 Mn $1.5 Bn 11.7% –
Digital Therapeutics $2.9 Bn $16.3 Bn 19% –
Digital Twin $714 Mn $5.3 Bn 22.3% –
Digital X-ray $7.3 Bn $10.6 Bn 3.8% –
Electronic Health Record $15.2 Bn $18.8 Bn 2.2% –
Healthcare Information System $121.9 Bn $497.4 Bn 15.1% –
Healthcare IT $202.7 Bn $545.1 Bn 10.4% –
Home Healthcare $152.1 Bn $269.8 Bn 5.9% –
Internet Of Things In Healthcare $41.8 Bn $169.2 Bn 15% –
IoT in Healthcare $75.9 Bn $309.5 Bn 15.1% –
Long-term Care Software $1.5 Bn $4 Bn 10.6% –
Mental Health Apps $2.4 Bn $13.1 Bn 18.7% –
Pathology Imaging Systems $680 Mn $1.7 Bn 9.9% –
Point of Care Diagnostics $19.1 Bn $32.3 Bn 5.4% 3,475
Remote Medication Management $1.6 Bn $6.6 Bn 15% –
Remote Patient Monitoring $664 Mn $2.9 Bn 15.8% –
Werable Healthcare Devices $13.7 Bn $70.5 Bn 17.8% –
Healthcare Services 24 markets
Healthcare Services markets in US
Market20232033 (projected)CAGR Active trials
Alopecia areata – – – –
Alzheimers Dignostic $882 Mn $1.4 Bn 4.9% –
Ambulance Service $13.1 Bn $21.6 Bn 5.1% –
Ambulatory Surgery Center $16.8 Bn $25.1 Bn 4.1% –
Antimicrobial Susceptibility Testing – – – –
Bioinformatics $5.1 Bn $16.5 Bn 12.4% –
Biomaterial Wound Dressing $3.4 Bn $5.5 Bn 4.7% –
Blood Gas and Electrolyte Analyzers $1.2 Bn $1.8 Bn 4.4% –
Bone Cancer Diagnostic $462 Mn $782 Mn 5.4% –
Brain Cancer Diagnostic $630 Mn $1.9 Bn 11.6% –
Breast Cancer Diagnostic $1.7 Bn $3 Bn 5.8% –
Clinical Laboratory Service – – – –
Dental Care Service – – – –
Dental Imaging $1.4 Bn $2.5 Bn 5.9% –
Dermatology Diagnostic $10.9 Bn $26.3 Bn 9.2% –
Fertility Service $8.8 Bn $13.2 Bn 4.1% –
Healthcare Electronic Data Interchange (EDI) $1.7 Bn $3.4 Bn 7.4% –
Healthcare In Vitro Diagnostic $35.1 Bn $41.9 Bn 1.8% –
Hospitals and Health Systems $1,829.7 Bn $2,606 Bn 3.6% –
Medical Billing $1.9 Bn $4.6 Bn 9.4% –
Medical Tourism $31.2 Bn $82.3 Bn 10.2% –
Nursing Education $4.3 Bn $7.8 Bn 6.1% –
Patient Support Programs (PSP) $7.2 Bn $26.3 Bn 13.8% –
Point Of Care (PoC) Molecular Diagnostic $7.9 Bn $15.9 Bn 7.3% –
Medical Devices 27 markets
Medical Devices markets in US
Market20232033 (projected)CAGR Active trials
Acute Care Needleless Connectors $206 Mn $352 Mn 5.5% –
Advanced Bipolar Direct Energy Devices $1.3 Bn $2.5 Bn 6.7% –
Aesthetic Lasers and Energy Devices $680 Mn $1.8 Bn 10.1% –
Air Ambulance Life Support Solutions $1.9 Bn $3.7 Bn 7.1% –
Airway Management Devices $840 Mn $1.2 Bn 3.2% –
Anastomosis Devices $1.3 Bn $2.1 Bn 4.8% –
Anesthesia & Respiratory Devices $12.1 Bn $24.8 Bn 7.5% –
Anesthesia Monitoring Devices $1.1 Bn $3 Bn 10.5% –
Angiography Devices $5.2 Bn $8 Bn 4.3% –
Angioplasty Balloons $1.7 Bn $2 Bn 1.8% –
Anti-Snoring Devices $525 Mn $1 Bn 6.8% –
Apheresis Equipments $1.1 Bn $1.6 Bn 4.2% –
Arrhythmia Monitoring Devices $2.5 Bn $3.6 Bn 3.5% –
Assisted Walking Aids $966 Mn $1.4 Bn 3.5% –
Audiology Devices $3.3 Bn $5.1 Bn 4.4% –
Defibrillator $7.4 Bn $10.9 Bn 3.9% –
Dental Articulators $164 Mn $252 Mn 4.4% –
Dental Caries Detectors $155 Mn $396 Mn 9.8% –
Dental Diagnostic and Surgical Equipments $5 Bn $8.3 Bn 5.1% –
Dental X-Ray Equipments $735 Mn $1.2 Bn 5.2% –
Diabetes Care Devices $17.9 Bn $26.2 Bn 3.9% –
Digital Diabetes Management – – – –
Direct Energy Medical Devices $4.6 Bn $6.2 Bn 3% –
Disposable Surgical Devices $3.8 Bn $6.4 Bn 5.3% –
Insulin Delivery Devices $6.7 Bn $10.4 Bn 4.5% –
Insulin Patch Pumps $374 Mn $970 Mn 10% –
Rehabilitation Equipments $8.4 Bn $12.6 Bn 4.1% –
OTC & Nutraceuticals 48 markets
OTC & Nutraceuticals markets in US
Market20232033 (projected)CAGR Active trials
Adaptogens $3.4 Bn $6.4 Bn 6.5% –
Amino Acid – – – –
Anthelmintic Drug – – – –
Antioxidants – – – –
Antipyretics OTC – – – –
BCAA Supplement $588 Mn $931 Mn 4.7% –
Beauty Supplements $1.7 Bn $3.5 Bn 7.2% –
Biotin Supplement $168 Mn $226 Mn 3% –
Bone & Joint Health Supplements $5 Bn $7.8 Bn 4.4% –
Calcium Supplements $1.1 Bn $1.6 Bn 4% –
Cannabidiol (CBD) Supplements $2.2 Bn $8.9 Bn 14.8% –
Cardiovascular Health Supplements $2.9 Bn $4.1 Bn 3.7% –
Clinical Nutrition $12 Bn $19.7 Bn 5.1% –
Coenzyme Q10 $210 Mn $413 Mn 7% –
Collagen Supplements $924 Mn $1.4 Bn 4.1% –
Creatine $252 Mn $384 Mn 4.3% –
Dietary Supplements $129.4 Bn $195.2 Bn 4.2% –
Eye Health Supplements $1.3 Bn $2 Bn 4.2% –
Functional Food $119.7 Bn $189.5 Bn 4.7% –
Hair Growth Supplements $756 Mn $1.3 Bn 5.3% –
Herbal Supplements $34.4 Bn $59.4 Bn 5.6% –
Immune Health Supplement – – – –
Iron Supplement $840 Mn $1.3 Bn 4.5% –
Men's Health Supplements $7.6 Bn $12.1 Bn 4.8% –
Mood and Stress Supplements $4.4 Bn $8 Bn 6.1% –
Nutritional Supplements $161.7 Bn $258.4 Bn 4.8% –
Omega 3 Fatty Acid $1.7 Bn $2.9 Bn 5.4% –
Oncology Nutrition $882 Mn $1.5 Bn 5.3% –
Osteoporosis Supplements $1.3 Bn $2 Bn 4.5% –
Over The Counter (OTC) Analgesics $9.2 Bn $10.6 Bn 1.4% –
Over The Counter (OTC) Antifungal $1.1 Bn $1.3 Bn 1.8% –
Over The Counter (OTC) Consumer $63.4 Bn $86.9 Bn 3.2% –
Over The Counter (OTC) Drugs $74.8 Bn $97.6 Bn 2.7% –
Over The Counter (OTC) Gastrointestinal Drugs $2.4 Bn $2.8 Bn 1.9% –
Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs $6.1 Bn $7.5 Bn 2.1% –
Over The Counter (OTC) Ophthalmic Drugs $1.5 Bn $1.9 Bn 2.5% –
Over The Counter (OTC) Pharmaceuticals $74.8 Bn $97.6 Bn 2.7% –
Over The Counter (OTC) Sleep Aid Products $2.2 Bn $2.7 Bn 2% –
Over The Counter (OTC) Vitamins and Minerals $13.4 Bn $19 Bn 3.5% –
Plant-Based Supplements $5.2 Bn $9.3 Bn 6% –
Prebiotics $3.4 Bn $8.7 Bn 9.8% –
Probiotic Supplements for Gut Health $2.6 Bn $4.3 Bn 5.2% –
Protein Supplement $8.4 Bn $14.2 Bn 5.4% –
Sports Nutrition $21.8 Bn $38.7 Bn 5.9% –
Vitamin B12(Cobalamin) $126 Mn $178 Mn 3.5% –
Vitamin D Supplements – – – –
Weight Management Supplement – – – –
Women's Health Supplements $8.4 Bn $13.4 Bn 4.8% –
Pharmaceuticals 38 markets
Pharmaceuticals markets in US
Market20232033 (projected)CAGR Active trials
Abuse Deterrent Opioids – – – –
Alexipharmic Drugs – – – –
Alopecia Drugs (Hair Loss) – – – –
Alzheimer Drugs $2.1 Bn $3.4 Bn 4.8% –
Aminoglycosides – – – –
Anemia Drugs – – – –
Anti-Aging $37 Bn $67 Bn 6.1% –
Anti-Depressants Drugs $7.6 Bn $8.1 Bn 0.7% –
Anti-Nerve Growth Factor – – – –
Anti-Venom – – – –
Anticoagulants – – – –
Antithrombotic Drugs – – – –
Artificial Skin $1.1 Bn $1.5 Bn 3.8% –
Asthma & COPD Drugs $20.8 Bn $25.3 Bn 2% –
Atherosclerosis Drugs – – – –
Atopic Dermatitis Drugs $4.7 Bn $12.5 Bn 10.2% –
Autologous Matrix-induced Chondrogenesis – – – –
Axial Spondyloarthritis (axSpA) – – – –
Biological Safety Testing – – – –
Biosimilar Monoclonal Antibodies – – – –
Biosimilars $15.5 Bn $121.8 Bn 22.9% –
Blood Plasma – – – –
Bone Marrow Aspirate Concentrates – – – –
Burn Care – – – –
Burn Ointment – – – –
Cancer Supportive Care Drugs $10.4 Bn $13.6 Bn 2.7% –
Cannabidiol (CBD) $9.3 Bn $36.8 Bn 14.8% –
Cannabis $14.2 Bn $42.3 Bn 11.5% –
Cell Based Immunotherapy $7 Bn $46.9 Bn 21% –
Contraceptives Drugs $10.6 Bn $16.9 Bn 4.8% –
Cord Blood Banking Service $798 Mn $1.2 Bn 4.5% –
Diabetes Management $32.8 Bn $53.9 Bn 5.1% –
Diabetic Retinopathy Drugs $4.5 Bn $6.7 Bn 4% –
Epilepsy Drugs $4 Bn $4.7 Bn 1.5% –
Gastroesophageal Reflux Disease (GERD) Drugs $2.2 Bn $2.2 Bn 0.1% –
Gastrointestinal Drugs $22.7 Bn $29.3 Bn 2.6% –
HIV Drugs $12.6 Bn $18.3 Bn 3.8% –
Oncology/Cancer Drugs $74.3 Bn $138.2 Bn 6.4% –

"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.

Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.

All 178 US reports Other countries